B2B Markeplace

In our modern society, pharmaceutical consulting firms are strategically positioned to help companies that are prominent in this dynamic field as they provide numerous additional elements to help the company survive through these difficult times. Generally, pharmaceutical consultants are industry experts and have often assumed key roles in other areas within the healthcare industry before joining the consulting organisation. As such, their recommendations do not come from books, but from a combination of experience, ability and passion for what they do.

Now more than ever, it’s important for the pharmaceutical company to make the right, strategic decisions as they develop new products and continue to market existing products into the field. The journey between product manufacture and the patient involves numerous layers of bureaucracy, regulatory restrictions and enforcement, even though the patient is much in need of a product. It is in such a taught environment that the pharmaceutical consultant can be worth his or her weight in gold.

Legislation is imminent which will change the look of the US healthcare industry (one of the world’s most complex industries) after decades. Even more uncertainty will be in evidence as organisations try to decipher what these changes will be all about, even as this process takes many months and years to unfold. This will be a period of learning for everyone and it goes without saying that the organisation that is best prepared, will capitalise the most from the opportunities ahead. Many view change as being a threatening situation, but for those who are forward thinking, they can see opportunities and will ensure that pharma consulting firms help them to delineate and take advantage accordingly.

The pharmaceutical and healthcare consulting firm should be selected on ability, its proven track record and its potential to help the company significantly. The consulting company must balance this experience with its ability to make judgements from a knowledgeable perspective and help to recommend that the organisation take certain steps to address specific challenges. The pharmaceutical consultant should be a close ally to senior decision-makers within the organisation and should provide a helping hand with expert input on a timely basis.

If key management decisions appear to be built on shaky ground, the pharmaceutical consultant should always be available and ready to implement a challenge to these positions, if better tactics and an alternate approach could result in a more profitable outcome. The consultant will not take over the situation of course, but a good consulting firm is quite able to look at the situation from a “devil’s advocate” or neutral and unbiased position, calling on knowledge and experience of similar situations in the past.

A pharma consulting firm should be able to anticipate trends by looking into its crystal ball and making sure that the organisation is advised of any potential threats or emerging issues that it should be aware of, if likely to impact a position. Developments within the marketplace could be critical to a planned product down the road and early intervention at decision-making time can often make the difference between great profits or a failed venture. The relationship between the pharmaceutical consulting firm and senior executives of the company should be close, established and proven, with a track record of positive outcomes.

Alan Gillies is the Managing Director of L2L Consulting, specialising in enabling pharmaceutical companies to achieve new heights of productivity and performance, throughout all levels of management and revenue generating activities.